1Clarkson A, Choonara L Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child, 2002, 87: 462-466.
2Jaeschke H, Gores GJ, Cederbaum AI, et aL Mechanisms of Hepatotoxicity. Toxicol Sci, 2002, 65 : 166-176.
3Knight TR, Fariss MW, Farhood A, et aL Role of lipid peroxidation as a mechanism of liver injury after acetaminophen overdose in mice.Toxicol Sci, 2003, 76: 229-236.
4Graziadei IW, Obermoser GE, Sepp NT, et al. Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. Lupus,2003, 12 : 409-412.
5Bohan A, Boyer JL. Mechanisms d hepatic transport of drugs:implications for cholestatic drug reactions. Semin Liver Dis, 2002,22: 123-136.
6Buratti S, Lavine JE. Drugs and the liver: advances in metabolism,toxicity, and therapeutics. Curr Opin Pediatr, 2002, 14 : 601-607.
8Konig SA, Schenk M, Sick C, et al. Fatal liver failure associated with valproate therapy in a patient with Friedreich' s disease : review of valproate hepatotoxicity in adults. Epilepsia, 1999, 40: 1036-1040.
9Fayad M, Choueiri R, Mikati M. Fatality from hepatitis A in a child taking valproate. J Child Neural, 2000, 15: 135-136.
10Krahenbuhl S, Brandner S, Kleinle S, et al. Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure.Liver, 2000, 20: 346-348.
